Med chem of antifungal agents Flashcards

1
Q

Which location of fungal infections are most concerning because they may become invasive?

A

Subcutaneous
-Fungi are generally implanted in the skin
-Fungal growth produces a lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Systemic/invasive fungal infection

A

-Fungi have invaded deep tissues
-Can be self-limiting or cause severe disease with high mortality rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antifungal drugs and targets: mimic _____ that are mainly found in fungal infections

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which drugs are considered polyenes?

Does it absorb in the gut well?

A

Amphotericin B

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Main features of polyenes

A

-Amphoteric: has both acidic and basic groups
-Contains a lipophilic polyene region (bottom) and a hydrophilic polyalcohol region (top)
-Macrolide ring
-Fungicidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Amphotericin B MOA

A

-Binds ergosterol = predominant sterol in fungal cell membranes
-Specificity: binds ergosterol with higher affinity than cholesterol
-Creates pores in cell membrane –> allows ions to leave and cells die
-Withdraws ergosterol from membrane –> instability of fungal cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PK of amphotericin B
-______ absorbed from GI tract
-_____ form is only effective for GI infections
-_____ form for systemic infections
-______ therapy needed for fungal meningitis

A

-Poorly absorbed from GI tract
-Oral amphotericin B ONLY effective for GI infections
-IV injection is required for systemic infections
-Intrathecal therapy is needed for fungal meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ADR of amphotericin B
-May premedicate with _____ to help reduce ______ related ADR

-____ damage
*Reversible component: ______
*Irreversible component: _____

-_____ abnormalities occasionally observed

A

-Toxicity is low enough to allow use, but still very toxic
-Infusion related (fever, chills) –> may be reduced by reducing the infusion rate
***Premedicate with diphenhydramine and/or acetaminophen

-Renal damage
**Reversible component=reduced renal perfusion
**Irreversible component = renal tubular injury (permanent kidney damage) –> usually occurs after prolonged administration (> 4 grams)

-Liver abnormalities occasionally observed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Amphotericin B in systemic infections

A

-Broad spectrum antimycotic
**Trying to disrupt fungal cell membrane
**Broad spectrum antimycotic
**Drug of choice for life-threatening fungal infections
-IV administration over 1-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Amphotericin B in superficial fungal infections (what is the name of the medication?)
**Oral thrush; infection on skin

A

-Nystatin - polyene drug similar to amphotericin B
**Too toxic for systemic administration so cannot be used IV b/c it will damage healthy human cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amphotericin formulations

A

-Conventional amphotericin B (Fungizone)
*Colloidal suspension
*Deoxycholate (a bile salt) used as a solubilizing agent

-Lipid formulation (Amphotec)
*Colloidal dispersion
*Encapsulated liposomal amphotericin B (ambisome)
*Amphotericin B lipid complex (Abelcet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lipid formulations of amphotericin
-Lipid formulations reduce _________
-Act as a _____ of amphotericin

-______ also reduces infusion toxicity bc it uses ____

-______ has less nephrotoxicity, but potentially more fever

A

-Nephrotoxicity

-Reservoir (encapsulated to get to target of fungal cell membrane)

-Ambisome; true liposomes

-ABCD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

-Most fungi have _______ in their cell membranes
**Plays the same role as cholesterol in mammalian cell membranes

A

-Ergosterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ergosterol synthesis pathway

A

Squalene (poisonous; disrupts fungal cell membranes) is converted to squalene epoxide via squalene epoxidase. Squalene epoxidase becomes lanosterol via CYP450 14alpha-demthylase which becomes ergosterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Terbinafine MOA

A

-Disrupts ergosterol synthesis by inhibiting squalene epoxidase –> causes a build up of squalene which disrupts the fungal cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Terbinafine has minimal SE because it hits the ____ enzyme at a much lower concentration (greater selectivity for the _____ enzyme compared to ____ enzyme)

A

Fungal

Fungal; mammalian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Terbinafine is available for ____ & ____ administration

A

Oral; topical
**Because of high selectivity of fungal enzymes, it is safe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What kinds of infections is terbinafine best used for?

A

Skin and nail fungal infections
-Ringworm, pityriasis versicolor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Naftifine (Lotrimin) and butenafine (Lotrimin Ultra) are chemically similar to _____ and have the same MOA
**Available OTC

Tolnaftate has a different structure than terbinafine, but also inhibits _______

**Only available in ____ preparations

A

Terbinafine

Squalene epoxidase

Topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Key feature of azoles

A

5-membered aromatic ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Azoles MOA

A

Inhibits 14 alpha-demethylase (inhibits demethylation reaction)

Fungistatic (inhibit fungal growth w/o killing the cell)

***Leads to cell death due to lack of ergosterol which is essential in the fungal cell membrane

**Azoles bind the iron in the catalytic site of Cytochrome P450 to prevent lanosterol binding –> get a build up of lanosterol and starving the cell of ergosterol –> accumulation of toxic sterols in cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Azoles selectivity

A

-Humans use the same enzyme to make cholesterol for our cell membranes
-Fungal enzymes are thousand fold more selective than human enzymes
-Azoles inhibit other mammalian CYP450s, so must monitor drug-drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Azoles metabolism

A

-Extensively metabolized by CYP450s
-All metabolites are inactive
-Only those azoles with reduced metabolism are used for systemic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Ketoconazole
-First azole with sufficient ____ bioavailability to be used clinically for _________________
-Based on ______

A

Oral; deep tissue infections

Miconazole
-Dioxolane ring on asymmetric carbon
-Reduced metabolism by CYP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Itraconazole -Based on _____ -_____ instead of imidazole -Modified substituent on dioxolane ring -Improved specificity for fungal ____ enzyme
Ketoconazole Triazole P450
26
Fluconazole -Substantially modified from ketoconazole *____ in place of imidazole *___ in place of Cl on benzene ring *____ and 2nd triazole on asymmetric carbon *Dioxolane ring eliminated
Triazole F Hydroxyl
27
Voriconazole -Based on _____ *Maintains triazole, hydroxyl, and ___ substituents *2nd triazole replaced with ______ *Added ____ group improves binding to fungal 14 alpha - demethylase and increases the spectrum
Fluconazole Fluorine Fluoropyrimidine ring Methyl
28
Posaconazole -Derived from _____ *Has_____ ring *_____ replaces Cl *_____ spectrum of activity * Available for ___ (as suspension) and ___ admin
Itraconazole Furan F Broad oral; IV
29
Isavuconazole -Structurally similar to ____ -_____ spectrum activity (similar to voriconazole, but also zygomycetes) -____ soluble prodrug **______ not required for solubility **______ nephrotoxicity relative to voriconazole **___ half life **Prodrug is _______ **Cleaved by _____ -Very fast -Release active drug and pro-drug cleavage product -Cleavage product has ______ half-life
Voriconazole Broad Water Cyclodextrin Reduced Long Isavuconazonium Plasma esterases short
30
Oteseconazole -Used for ____ fungal/yeast infections (reoccurring) -_____ tx outcomes compared to fluconazole -Selective inhibition of the fungal enzyme ____ (a 14-alpha demethylase) -Lower number of ADR
High risk Improved CYP51 **More worried about drug-drug interactions
31
-In general, azole antifungals are metabolized and inhibit liver _______ enzymes *Triazole concentrations can be increased by other drugs metabolized by this pathway *Concentration of drugs metabolized by CYP enzymes can be increased *Inducers of CYPs can _____ triazole levels ~_____ is a potent inducer
CYP450 Decrease Rifampin
32
Ketoconazole and CYP450 -Ketoconazole is a potent ____ of CYP3A4 -Drug interactions *Inhibited metabolism of terfenadine & cisapride (off market) *_______ bioavailability of cyclosporin *CYP3A4 inducers (rifampin) _______ ketoconazole levels
Inhibitor Increases reduce
33
Azole metabolism -Itraconazole is extensively metabolized by ____ in liver -Fluconazole is 80% _____ by the kidney unchanged -Voriconazole is metabolized extensively in the liver by _____ > CYP3A4 >> CYP2C9 -Posaconazole is metabolized in the liver by ______
CYP3A4 excreted CYP2C19 Glucuronidation
34
Echinocandins: lipopeptides -Synthetically modified fungal compounds -Examples (3) -All must be administered ____
Caspofungin, Micafungin, Anidulafungin IV
35
Structure of echinocandins
-Cyclic hexapeptides with long, modified fatty acid side chains
36
MOA of echinocandins -Inhibit the synthesis of ____ (cell wall component) ***Makes _____ for cell wall to be stable -Reason for selectivity: _____ -Fungicidal: _____ -_____ spectrum of activity -Cross resistance with other antifungals???
-Beta (1-3) glucan = target enzyme ***Crosslink Mammalian cells lack beta (1-3) glucan Destabilizes the membrane and causes leaky cells to die Broad (synergistic with voriconazole and amphotericin B) NOPE!
37
_______ is required for chitin production
Beta (1,3) glucan; when these are depleted, it weakens the membrane --> good because structure is not similar in humans so it targets the fungal cell
38
Beta (1,3) glucan is normally located at the tip of the ____; echinocandins cause those to ____
Hyphae Burst/break
39
Caspofungin use
-Disseminated & mucocutaneous candida -Salvage tx in pts with aspergillosis who fail to respond to amphotericin B
40
Micafungin use
-Mucocutaneous candida -Candida prophylaxis in bone marrow transplant pts
41
Anidulafungin use
-Esophageal candidiasis -Invasive candidiasis -Has longest half-life & no known drug interactions ****NOT disrupting/inhibiting human enzymes
42
Which fungins are associated with fewer ADR
Micafungin Anidulafungin
43
Metabolism of echinocandins -Degraded in _____ & _____
-NOT metabolized by liver CYPs (not stable bc they have a lot of ring opening by proteases) -Blood & tissues *Ring opening *Peptide hydrolysis
44
Rezafungin -Novel, ____ (frequency) echinocandin antifungal for adults with ______. -____ administrations, semisynthetic molecule that inhibits the beta-glucan synthase enzyme. -Much _____ half-life than other echinocandins, which allowed for _____ dosing instead of continuous IV.
Once weekly; limited or no alternative tx options (candidiasis) IV Longer; once weekly
45
Ibrexafungerp (own class); targets the same thing as echinocandins, but has a different structure -____(route of admin), small molecular inhibitor of _____ enzyme in fungi -Triterpenoid antifungal that inhibits glucan synthase, depleting ____ and acting as a fungicidal.
Oral; glucan synthase (similar to glucocandins, but these are smaller so they can be given PO) -1,3 -beta-D-glucan
46
Ibrexafungerp is mostly active against candida and used for________ It is metabolized by hydroxylation via ____ and then via ______ & ____ Well-tolerated due to the selective activity against the glucan synthase enzyme
Vulvovaginal candidiasis Hydroxylation; glucuronidation & sulfation
47
Flucytosine MOA
Antimetabolite (pyrimidine analog) -Inhibits thymidylate synthase -Interferes with protein synthesis **Prodrug in fungal infection
48
Reasons for flucytosine specificity
Mammalian cells are unable to convert flucytosine to active metabolite, so it only targets fungal cells
49
Flucytosine synergizes with _______
Amphotericin B
50
Flucytosine must go through the ______ to enter the cytoplasm It ultimately becomes _____ which is an active compound that inhibits dTMP which would have become _____ to extend the DNA chain ***prevents ____ from being created
Cytosine permease transporter 5-FdUMP Triphosphate Nucleic Acids
51
Flucytosine is first converted by cytosine deaminase to _____ *Phosphorylated to form 5-FdUMP *5-FdUMP mimics ______ *5-FdUMP is a substrate, a competitive inhibitor, and a suicide inhibitor of ________ *In 5-FdUMP, there is a F in place of H found in dUMO *F is the most electronegative atom, so it cannot be _____ *Thymidylate synthase gets trapped in an ______ form and cannot react with ______ *No dTMP can be produced --> inhibits ________
5-fluorouracil dUMP thymidylate synthase eliminated inactive; dUMP DNA synthesis
52
Flucytosine PK -Available only in _____ form -Penetrates well into all fluid compartments including CSF -Removed by _____ -_______ impairment can lead to toxicity
Oral Kidney Renal
53
Flucytosine ADR
-Intestinal flora can metabolize to 5-FU (anti-cancer drug) -Monitor levels when combined with amphotericin bc both can cause kidney toxicity
54
Clinical uses of flucytosine
-Limited spectrum of activity *Cryptococcus neoformans (combined with amphotericin B for cryptococcal meningitis) *Some Candida spp *Aspergillus *Most filamentous fungi are not susceptible
55
Flucytosine has a ____ therapeutic window
Narrow *Concentration too high = toxicity *Concentration too low = resistance (can come from deamidase or protease)
56
Flucytosine is nearly always administered with ____ or ____
Amphotericin B or fluconazole
57
Griseofulvin MOA
-Disrupts fungal microtubules -Fungistatic (by slowing down growth & division of cells) -Must be given PO (becomes incorporated in keratin precursor cells)
58
Griseofulvin is used for ______ It is inactive against ______
Dermatophytes (skin, hair, nails) --> more toxic than azoles, so it is not used topically Inactive against yeast, mold & dimorphic fungi -- not absorbed
59
Tavaborole MOA -___ is essential for activity -Topical tx for _______
Inhibits leucyl transfer RNA synthetase (LeuRS) --> inhibits protein synthesis in fungal cells Boron Onychomycosis (nail fungus)
60
Resistance from candida krusei
INTRINSIC resistant to fluconazole reduced susceptibility to flucytosine & amphotericin B
61
Resistance from candida glabrata
Multiazole Echinocandin Multidrug resistance **Mutations in enzymes that can arise which may lead to 'R'
62
Resistance from aspergillus terreus
Intrinsically resistant to amphotericin
63
Antifungal tx has altered the types of fungi associated with infection --> ______ used to not commonly be isolated, but is very common today
C. glabrata
64
Resistance to antifungal agents: acquired resistance _____ transferred between strains in bacteria
is not **No plasmid-based sharing
65
Resistance to azoles
-Target site alteration -Reduced drug concentration via efflux pumps -Target enzyme upregulation -Development of bypass pathways -Increasingly common. esp Aspergillus
66
Resistance to Polyenes
Reduced ergosterol content
67
Resistance to Echinocandins
-Beta (1,3) glucan mutations (RARE)
68
Resistance to flucytosine
Cytosine deaminase or UPRT (cytosine permease)
69
Antifungal toxicities: hepatic
All azoles (DDI-CYP3A4) Amphotericin B 5-FC Echinocandins
70
Antifungal toxicities: renal
Amphotericin B (greater than 4 g) IV voriconazole (bc combined with cyclodextrins)
71
Antifungal toxicities: CNS
Voriconazole
72
Antifungal toxicities: photopsia
Voriconazole
73
Antifungal toxicities: cutaneous
Rash (all antifungal agents) Photosensitivity/malignancy (voriconazole)
74
Antifungal toxicities: GI
Itraconazole Posaconazole 5-FC **b/c can metabolize drugs to anti-cancer
75
Antifungal toxicities: cardiac
Cardiomyopathy (itraconazole) QTc prolongation (all azoles, esp with DDI)
76
Antifungal toxicities: infusion rxn
Amphotericin B Echinocandins
77
Antifungal toxicities: bone marrow suppression
5-FC Amphotericin B (anemia associated with decreased epoetin production)
78
Antifungals during pregnancy -_______ tx are OK -____ is treatment of choice for systemic infections bc it does not cross the placenta well
Topical Amphotericin B
79
Fluconazole, itraconazole, posaconazole, and isaconazole use in pregnancy
AVOID in pregnant women, esp 1st trimester -Possibility of birth defects & spontaneous abortion -Single dose of fluconazole 150 mg to tx vaginal yeast infection does not appear to be associated with the birth defects
80
Voriconazole, flucytosine, and griseofulvin use in pregnancy
CONTRAINDICATED --> fetal abnormalities observed in animals
81
Echinocandins used in pregnancy
Not enough data -- use is cautioned